Pharmacogenomics Market is Estimated to Witness High Growth Owing to Advances in Genomic Technologies

Pharmacogenomics Market The pharmacogenomics market involves understanding how an individual's genetic inheritance affects his ability to respond to drugs. It combines pharmacology and genomics to develop effective, safe medication and drug dosage personalized to an individual's genetic makeup. Pharmacogenomics testing helps determine the most suitable drug, its dosage and duration to maximize effectiveness and minimize adverse reactions. The Global pharmacogenomics market is estimated to be valued at US$ 1.9 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2030. Key Takeaways Key players operating in the pharmacogenomics market are Daimler AG, Ford Motor Company, Renault SA, Ashok Leyland Ltd, VE Commercial Vehicles Limited, Tata Motors Ltd, SML Isuzu Limited, GM Group, Mahindra & Mahindra Ltd, Volkswagen AG, Toyota Motor Corporation and Stellantis NV. Key players like Daimler AG are focusing on developing genetic testing to person...